Polar Asset Management Partners Inc. acquired a new stake in Translational Development Acquisition Corp. (NASDAQ:TDACU – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 800,000 shares of the company’s stock, valued at approximately $14,752,000.
A number of other institutional investors have also made changes to their positions in the stock. AQR Arbitrage LLC bought a new position in shares of Translational Development Acquisition in the 4th quarter valued at approximately $27,383,000. Magnetar Financial LLC bought a new position in Translational Development Acquisition in the 4th quarter worth approximately $23,972,000. LMR Partners LLP bought a new position in Translational Development Acquisition in the 4th quarter worth approximately $14,752,000. K2 Principal Fund L.P. bought a new position in Translational Development Acquisition in the 4th quarter worth approximately $12,447,000. Finally, Hudson Bay Capital Management LP bought a new position in Translational Development Acquisition in the 4th quarter worth approximately $11,986,000.
Translational Development Acquisition Trading Up 0.4%
Shares of NASDAQ TDACU opened at $10.27 on Thursday. The stock has a 50 day simple moving average of $10.19. Translational Development Acquisition Corp. has a 12 month low of $10.00 and a 12 month high of $10.30.
Translational Development Acquisition Company Profile
Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector.
See Also
- Five stocks we like better than Translational Development Acquisition
- What is a Stock Market Index and How Do You Use Them?
- Analysts Say Unilever Has the Leverage to Hit New Highs
- Are Penny Stocks a Good Fit for Your Portfolio?
- Homebuilders: Oversold, Undervalued, and Ready to Run?
- What is Put Option Volume?
- SMCI Stock Rally: 45% Gain in 2 Days Could Be Just the Start
Want to see what other hedge funds are holding TDACU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Translational Development Acquisition Corp. (NASDAQ:TDACU – Free Report).
Receive News & Ratings for Translational Development Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Translational Development Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.